PUBLISHER: TechNavio | PRODUCT CODE: 1067500
PUBLISHER: TechNavio | PRODUCT CODE: 1067500
Technavio has been monitoring the anorexiants market and it is poised to grow by $ 1.05 bn during 2022-2026 progressing at a CAGR of 4.62% during the forecast period. Our report on the anorexiants market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing obese population, increasing government initiatives for healthcare infrastructure, and vendors strategies such as mergers and acquisition (M and A) activities.
The anorexiants market analysis includes the distribution channel segment and geographic landscape.
Technavio's anorexiants market is segmented as below:
By Distribution Channel
By Geographical Landscape
This study identifies the research and approval of new drugs as one of the prime reasons driving the anorexiants market growth during the next few years. Also, awareness about weight management and increase in childhood obesity and morbid obesity incidence will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on anorexiants market covers the following areas:
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading anorexiants market vendors that include Arena Pharmaceuticals Inc., Bausch Health Companies Inc., Currax Pharmaceuticals LLC, Elite Pharmaceuticals Inc., Epic Pharma LLC, F. Hoffmann La Roche Ltd., Hi Tech Pharmaceuticals, Johnson and Johnson, KVK Tech Inc., Lannett Co. Inc., Novartis AG, Novo Nordisk AS, Nuvo Pharmaceuticals Inc., Pfizer Inc., Recordati SpA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Virtus Nutrition LLC., VIVUS LLC, and Zydus Lifesciences Ltd. Also, the anorexiants market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.